The present invention provides a blood glucose elevation inhibitor having a serine protease inhibitory action, which is a novel therapeutic or prophylactic agent for obesity. A compound represented by the following formula (I)
wherein each symbol is as described in the specification,
or a pharmaceutically acceptable salt thereof.
                            本发明提供了一种具有
丝氨酸蛋白酶抑制作用的血糖升高
抑制剂,该
抑制剂是一种新的肥胖症治疗或预防剂。该化合物的结构式如下(I),其中每个符号如规范中所述,或其药学上可接受的盐。